Treatment of soft and hard connective tissues especially those associated with massive tissue loss is technically demanding. Tendon and cartilage have low healing capability. Massive bone injures are often associated with nonunion or malunion and other complications. Treatment of tendon-bone junction is challenging and treatment of osteoarthritis is more palliative than curative. Tissue engineering which composed of three elements including scaffolds, healing promotive factors such as growth factors, and stem cells is an option. Recently stem cell based therapy is much popular due to the encouraging reported results. This review introduced stem cells and discussed their potential application and roles in tissue regenerative medicine. We have focused on the effectiveness of stem cells based therapy on different tissue injuries, including tendon, tendon to bone junction, bone, cartilage and osteoarthritis. In vitro to clinical evidences have been discussed in detail with the aiming to conclude whether stem cell based therapy is a clinically accepted method. This review showed that despite of exploring several sources for the stem cells, the adult mesenchymal stem cells are still the only reliable stem cells in tissue regenerative medicine.
Introduction
Treatment of injured tendon, ligament, cartilage and bone often has faced with some difficulties [1] [2] [3] . Such tissues tolerate different types of forces such as stress, torsion and bending, during healing which affect their healing and if not properly managed, ideal healing would not be expected [4] [5] [6] [7] [8] . In addition such soft and hard connective tissues have low healing capability because their circulation is often impaired due to the injury 2 . Some of the tissue injuries can be directly repaired surgically 9, 10 . For example simple tendon ruptures could be sutured and anastomosed 11 . Simple fractures could be fixed with a variety of external and internal fixation techniques and devices. However, some of the tissue injuries are engaged with significant tissue loss and could not be retrieved by routine surgical methods 2 . In large massive tendon injuries the gap should be reconstructed by auto or allografts 2 . In large massive bone fractures or other types of bone injuries such as osteosarcoma there is a need to resect diseased bone, and despite of intensive fixation of the bony ends, large gap is produced. In such condition the gap area should be reconstructed by a cancellous bone graft or other types of graft based on the experience and preference of the surgeon [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] .
Tissue transplantation has its own limitations and it is widely accepted that there is a need for alternative solutions 2 .
There are also some other orthopedic injuries that could not be solved with only grafting methods. For example, in ACL reconstruction, although a torn ACL is replaced by auto or allograft, however, major concerns exist for the ligament to bone healing 22, 23 . Most of the failures occur at this site and this is a major problem 24 . Healing of cartilage is also extremely slow and if osteoarthritis (OA) happen the condition becomes more complicated and there is no well accepted method for retrieving such conditions [25] [26] [27] [28] [29] . Most of the gold standard methods are palliative, and if they are effective; they can only reduce the rate of OA progression [30] [31] [32] . Therefore, there is a need to find a new way with the hope that such injuries will heal with minimum complication and be functional after the healing period.
Tissue engineering is one of these new approaches 2, 33 . In the last decade, several advancements have been achieved and the tissue engineering technologies and tissue engineered based products have been developed and produced 33 .
The initial tests have been represented encouraging results however, the results are still primitive and several animal and clinical studies are needed to prove such a new option 2 . Basically, tissue engineering can be divided into three major categories. Scaffolds are the first category and have many roles. They can be implanted to act as a tissue 4 conductor and guide the healing tissue in a desired manner 2, 10 or behave as a vehicle for growth factors and stem cells 2, 3, 10 . The second category is the healing promotive factors 2,3,10 such as growth factors. Basic fibroblast growth factor (bFGF), bone morphogenic protein 2,4,7 (BMP 2,4 & 7), vasculoendothelial growth factor (VEGF), tissue growth factor B (TGFB), platelet derived growth factors (PDGF) are some examples [1] [2] [3] 9 . These growth factors have many roles in tissue regeneration and regulate different stages of wound healing 3 . Platelet rich plasma (PRP) is a simple and inexpensive source for the growth factors and can be widely used in clinical practice 3 .
Glycosaminoglycans such as hyaluronic acid and chondroitin sulfate have important roles during tissue healing 5, 11, [34] [35] [36] and could be considered as other healing promotive factors 2 . Finally, the third category is the stem cells. Much advancement has been achieved in this field of regenerative medicine and the primitive results are encouraging.
Stem cells have crucial roles in tissue regeneration because they can collaborate in matrix synthesis and result in potential enhancement of the quality and integrity of the healing tissues 2 . An ideal tissue engineering approach should combine all these three elements to produce an appropriate tissue engineered graft 2 . However most of the studies have focused on the role of each category and did not combined them in a manner to be applicable in clinical practice 2 .
In this review we have introduced stem cells, their roles in tissue healing and provided some evidences to show whether they are effective in restoring structure and function of the injured tissues. Several in vitro and in vivo 
Stem cells
Recently much attention has been paid on stem cells 37, 38 . Stem cells have the potential to divide and differentiate into various specialized cell types and can self-renew to produce more stem cells 39 ( Fig. 1 and 2 . The matrix then gradually organizes and the structure and integrity of the injured area are restored. By an increase in the number of stem cells in the injured area, it is possible to increase matrix deposition and therefore, accelerate the quality and rate of wound healing. This is the basic hypothesis that has motivated the researchers to use stem cells for wound healing.
Stem cells can be divided based on their self-renewal and Potency 38, 39 . Self-renewal is the ability to go through numerous cycles of cell division while maintaining the undifferentiated state. While potency is the capacity to differentiate into specialized cell types 40 ( Fig. 1 and 2 ). Based on the potency, stem cells can be divided into five groups 28, 41 . The first type is the totipotent stem cells 37 . These cells can differentiate into embryonic and extraembryonic cell types 40 (Fig. 2) . Such cells can construct a complete, viable organism 19, 42 . These cells are produced by fusion of an egg and sperm cell. The cells produced by the first few divisions of the fertilized egg are also totipotent. Actually the potency of these cells is the highest among other stem cell types
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. The second type is the pluripotent stem cells 43 . These cells are the progenies of totipotent cells and can differentiate into almost all cells ( Fig. 1 and 2 ). The cells derived from any of the three germ layers are examples of this type 19 . The third type is the multipotent stem cells 37 which can differentiate into a number of cells, but only those of a closely related family of cells 28 . The potency of these cells is much lower than the totipotent stem cells and lower than pluripotent stem cells.
The fourth type is the oligopotent stem cells. These cells can differentiate into only a few cells, such as lymphoid or myeloid stem cells 41 . Finally, the fifth group is the unipotent cells 13, 29 . The potency of these cells is extremely low so that they can produce only one cell type, their own. They have the property of self-renewal, which distinguishes them from non-stem cells 29, 44 . Therefore, all types of stem cells have the ability of self-renewal but their potency is different and depends on the source that they have arisen from 28 . There are many concerns in the stem cell therapy.
One concern is the risk that transplanted stem cells could transform to carcinogen cell lines and become cancerous if cell division continues uncontrollably 26, 29, 45, 46 .
Types of stem cells based on their source
Embryonic
These cells can be obtained from the epiblast tissue of the inner cell mass of a blastocyst or earlier morula stage of embryos (Fig. 2) 
Fetal
The primitive stem cells located in the organs of fetuses are referred as fetal stem cells. Fetal stem cell is one of the best sources for stem cells in veterinary medicine because all fetal tissues are composed of stem cells and without any difficulty these cells can be harvested from the fetus. However, fetal stem cell in human medicine is faced with ethical concerns and for this reason the researches in this area are limited 42 .
Adult
Adult or somatic stem cells can be found in children, as well as adults. Pluripotent adult stem cells are rare but can be found in a number of tissues including umbilical cord blood 18 . For autogenous adult stem cells, there are three accessible sources: 1) Bone marrow, which requires extraction by harvesting, that is, drilling into bone, typically the femur or iliac crest, 2) Adipose tissue (lipid cells), which requires extraction by liposuction, and 3) Blood, which requires extraction through pheresis, where blood is drawn from the donor, similar to a blood donation, passes through a machine that extracts the stem cells and returns other portions of the blood to the donor 15, 27, 29, 47, 48 (Fig. 1 ).
Bone marrow has been found to be one of the most reliable sources of adult stem cells which have been used in treating several conditions 31, 39, 41, 47, 49, 50 . The quantity of stem cells of bone marrow has been found to be declining with age 22, 51 . Most adult stem cells are multipotent and are generally referred to by their tissue origin (mesenchymal stem cell (MSCs), adipose-derived stem cells (ADSCs), endothelial stem cell, dental pulp stem cell, etc.) 22, 37 
Role of stem cells in tendon healing (Tables 1 and 4)
Tendon healing is a slow process. Tendon has low vascularity and is under tension during the healing process. After the injury, the cellularity is also not raised sufficiently to restore the structure and function of the tendon 2,5-8 .
Therefore, there is a need to increase the rate and quality of tendon healing. Stem cell therapy is one of the available options with encouraging results 2 . Different stem cells have been used by many to promote tendon healing. Adult stem cells are the most popular type; however aging reduces the potency of the stem cells 57 . Usage of growth factors may be an important step in the tissue engineering of human flexor tendons. Raghavan et al 58 showed that bFGF, insulin-like growth factor (ILGF), and platelet-derived growth factor (PDGF) improve culture conditions for human fibroblasts, tenocytes, and ADSCs and increase cellular proliferation and repopulation of a tendon scaffold in vitro.
One of the most scientifically tested stem cells is tendon-derived stem cells (TDSCs) that have recently been identified within tendon tissues 37 . TDSCs exhibit universal stem cell characteristics, such as clonogenicity, a high proliferative capacity, multi-differentiation potential, non-immunogenicity, and immunosuppression 37 . As a result, implanting TDSCs in the injured area may be an effective way for tendon regeneration 38, 59 . Ni et al 60 Achilles tendon transection model, in vivo and indicated that the treatment was not effective at least at gross pathology. Cell labeling showed that MSCs were viable even after 6 weeks and diffused in the intra tendinous area.
Although treatment improved collagen fiber alignment and biomechanical properties of the injured area at 3 weeks however at 6 weeks no significant difference were observed. It seems that MSCs has only a minor role and its role is limited to the early stages of tendon healing.
Caniglia et al 68 injected BMD-MSCs into the core defect in the superficial digital flexor tendon (SDFT) of horses. 
Role of Stem cells in Tendon to bone healing (Tables 2 and 4)
Fixation and incorporation of the ruptured rotator cuff tendon to bone is a major concern in rotator cuff repair surgery. Rotator cuff repair usually fails at the tendon-bone interface, especially in case of large or massive tears.
Similar concern exists for the reconstructed ACL 22, 23 . The torn ACL should be replaced by a new graft and the major concern is the difficulty to fix the tendon graft into the bone tunnel 22, 23 . The failure in most instances occurs at this site 22, 23 . In both cases, good fibrocartilageous zone should be developed and be mineralized to produce a strong tendon to bone attachment. Stem cells are used to improve the quality and rate of tendon to bone healing [22] [23] [24] 40, 82, 83 .
Nourissat et al 40 explored the benefits of a treatment based on injecting chondrocyte and MSCs in a rat model of degenerative enthesis repair. The Achilles' tendon was cut and the enthesis destroyed. The damage was repaired by classic surgery. Cell injection significantly improved healing and the load-to-failure after 45 days and it also produced new enthesis in the treated lesions.
Although, application of stem cells alone may have some effective roles in tendon to bone healing however, some studies have suggested that there is a need in inducing osteogenesis at this site so that the stem cells should be activated to produce bony structure. Studies revealed that stem cell differentiation may have more value in tendon to bone healing than tendon healing. Silva et al 84 showed that adult non-cultivated BMD-MSCs did not accelerate tendon-to-bone healing in the femoral tunnel, after hamstring ACL reconstruction in humans. Similarly, Gulotta et al 49 used allologous BMD-MSCs to treat rotator cuff tendon injury in rats. Addition of MSCs to the healing rotator cuff insertion site did not improve the structure, composition, or strength of the healing tendon attachment site. These disappointing results may be because the repair site may devoid of the cellular and/or molecular signals which are necessary to induce appropriate differentiation of transplanted cells. Rui et al 85 showed
that BMP-2 can differentiate the TDSCs so that it promotes the osteogenic, adipogenic, and chondrogenic differentiation but inhibit tenogenic differentiation in vitro. To assemble such growth factor with stem cells, a scaffold is needed. In addition, it seems the scaffolds have some beneficial role in tendon-bone healing. Yokoya et al 86 , seeded a polyglycolic acid sheet scaffold with MSCs and reconstructed infraspinatus tendon defect model in rabbits and indicated that MSCs were able to regenerate tendon-bone insertions and the tendon belly, and increased production of type I collagen, and mechanical strength of the regenerated rotator cuff tendon. Soon et al 23 also
analyzed the effect of coating allografts with MSCs on ACL graft healing after ACL reconstruction in rabbits. The treated group showed a mature zone of fibrocartilage blending from bone to the allograft, strongly resembling a normal ACL insertion. MSCs treated lesions also showed higher ultimate load but lower stiffness and Young's modulus compared to the control lesions. In a similar study Lim et al 22 studied the effect of coating tendon grafts with MSCs on the rate and quality of graft osteointegration in ACL reconstruction in a rabbit model. Treatment increased the quality of fibrocartilage zone histologically and higher amount of collagen type II was seen in these lesions. Also after 8 weeks, the treated lesions showed higher ultimate load and stiffness than controls.
Based on the above evidences it seems the role of scaffolds in tissue healing, which results in enhanced effectiveness of seeded stem cells should be highlighted. As suggested, an optimum tissue engineered product is composed of scaffold, growth promotive factor and stem cell. Such a construct is used to repair the tendon bone healing in vivo.
Chen et al 83 enhanced infraspinatus tendon-bone healing, using an injectable hydrogel made with rabbit periosteal progenitor cells and polydiacrylate tethered with BMP-2. Treatment improved production of collagen type II, aggrecan and fibrocartilage tissue. It also increased ultimate strength of the tendon-bone interface after 4 and 8 weeks.
Some others tried gene therapy to induce healing. Dong et al 87 used bone marrow stromal cells and infected these cells with recombinant BMP-2 virus to reconstruct ACL in rabbits and showed that treated samples had higher ultimate load and stiffness and better collagen fiber alignment than controls. Scleraxis is a basic helix-loop-helix transcription factor that is thought to lead tendon development during embryogenesis. Gulotta et al 56 determined that application of MSCs transduced with adenoviral-mediated scleraxis could improve regeneration of the tendon-bone insertion site in a rat rotator cuff repair model. Scleraxis improved fibrocartilage production with improved collagen fiber organization and increased tensile strength.
Use of different types of stem cells with lower potency, but in a more differentiation status has also been reported.
Mifune et al 24 showed that the ACL-derived CD34(+) stem cells could contribute to tendon-bone healing in rats.
These cells increased collagen production, angiogenesis and osteogenesis in vivo. In another study, Ju et al 82 investigated the role of synovial MSCs on tendon-bone (Achilles tendon was fixed within the tibial bone tunnel experimentally) healing in rats. Cell therapy increased proportion of collagen fiber area and sharpey's fibers and the cells were migrated in the tendon to bone junction during the first two weeks but the labeled stem cells were no longer observable after four weeks.
The effectiveness of stem cells in tendon to bone healing has been also reported in a limited number of clinical studies. Ellera et al 88 in a case series treated rotator cuff tears with conventional surgical technique but with aiding autologous BMD-mononuclear cells. They reported that the integrity of tendon was improved by the cells and the patients had proper outcome after one year follow up.
Role of stem cells in bone regeneration and healing (Tables 2and 4)
Bone healing has its own limitations and complications. Many cases of nonunion, malunion or osteomyelitis are presented yearly [89] [90] [91] . In addition in such cases associated with large massive bone defects, such as osteosarcoma, gunshot fractures, severe trauma, burn, etc, bone transplantation is needed, however a proper graft both in size and quality may not be available for such cases. Therefore, there is a need to accelerate bone healing to increase the amount of the newly regenerated callus in the defect area. Stem cells may have a role to aid bone formation in this regard. Several studies have been conducted in vitro and in vivo to test whether stem cell therapy is effective in achieving such a goal 12, [14] [15] [16] [18] [19] [20] [21] .
The osteogenic potential of MSCs has been previously suggested 92 . Also, it has been shown that this potential is stronger in autogenous MSCs. Niemeyer et al 16 After 8 weeks, complete bone union was obtained in the cell treated group however the control groups showed no bone union at this time.
It is suggested to use combined treatment modalities to increase the effectiveness of MSCs in bone healing. Many methods exist and an example is provided here. Cheung et al 21 investigated the effects of combined treatment of exogenous MSCs and low intensity pulsed ultrasound on fracture healing in rats. Treatment accelerated bone healing; however the MSCs had the major role in this regard.
Role of stem cells in cartilage healing and osteoarthritis (Tables 3 and 4)
The incidence of cartilage injury and osteoarthritis are high 30, 32, 46, 50 
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Discussion
This study comprehensively introduced stem cells as one of the treatment option in soft and hard connective tissue injuries. We showed that autologous MSCs are the most popular cells that widely tested in different species with encouraging results 17, 20, 22, 23, 41, 56, 69, 86, 98 . Although it seems that other types of stem cells are also effective in tissue healing and regeneration however the studies are insufficient to prove their efficacy 16 . Different sources of MSCs have been used by many investigators; however the most reliable sources seem to be both bone marrow and adipose tissues. Generally, cell therapy was found to be a safe method even with the allologous (e.g. embryonic stem cells) or xenologous forms 42 . Based on the reviewed reports, no adverse effects related to cell therapy were diagnosed 16 .
Despite of improvement in the tissue engineering technologies and presence of a large variety of scaffolds, commercially available in the market and or can easily be made in a laboratory, however cell seeding technology seems to be technically demanding and most of the studies, selected the direct injection method especially in the clinical studies rather than cell seeding [30] [31] [32] 50, 94 . However, it has been shown that tissue engineered based cell therapy has a superior potential in healing of injured tissues. This review also, showed that it is possible to differentiate stem cells with healing promotive factors such as BMP and this differentiation is well achieved in an in vivo condition. It seems in vitro cultivation and differentiation of the cells increase cell aging and decrease its healing efficacy 25, 68, [70] [71] [72] . Therefore, a proper design for such treatment modality should be based on three factors including, scaffold, healing promotive factors or cell differentiating agents, and stem cells. For better explanation, the stem cells should be seeded on a scaffold in laboratory without altering its differentiation 2, 19 . At time of implantation of the graft the differentiating factor should be added to the construct. This inhibits cell aging and increase the healing efficacy of the cells in the injured area. However, this conclusion was based on the presented results; perhaps, future studies could better clarify this phenomenon.
It is impressive and also interesting that clinical studies, support experimental animal studies 30, 32, 50, 65, 89, 90, 94 , however, several limitations exist that makes it hard to conclude. The first limitation is that, there are some controversies between the results of some studies. For example, theoretically autogenous MSCs should have higher viability in the injured area than the embryonic cells. However, some reports exist that ignore this statement 39, 42, 49, 68, 70 . This potentially could be an area of research for future works. There are also some studies that have not followed an standard pattern, and each had its own hypothesis and used different types of stem cells with different preparation methods and cell concentration 26, 51, 67, 82, 99 . Another limitation is the lack of human clinical trials studies.
Unfortunately, most of the recent clinical based studies are case reports or case series which shows that cell therapy is still in its primitive stages and is still under investigation (Table 4 ). The proportion of animal studies is extremely higher in this regard. Although the animal based studies mimic the human condition at least as compared with in vitro investigations, however it should be remembered that the animal studies are an approximation and each animal model has its own limitations and benefits. Potential limitations of the animal studies should be considered when the results are going to be generalized in clinical setting.
Conclusion
Cell therapy although has been shown to be an effective treatment in different tissue injuries, however there is no uniformity between the methods and no standard method has been selected as a gold standard. There are numerous animal studies which have tested these cells in different tissue injuries, however controversies exist and human clinical studies are mainly limited to case reports and case series and lack of well-designed clinical trial studies in this area of research gives this conclusion that cell therapy although interesting but is still in its primitive period. Embryonic stem cells are mostly derived from inner cell mass of the blastocyst and fetal stem cells can be obtained from different tissues of the fetus however, they are more tissue specific and more differentiated than embryonic stem cells.
